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Adipose tissue is responsible for insulating internal organs, storing energy for times of             
negative energy balance, and secreting adipokines into circulation. The major cell types found in              
adipose tissue include undifferentiated adipocytes (pre-adipocytes), adipocytes, and adipose         
tissue macrophages (ATMs). Adipocytes and ATMs are the major sources of adipokines,            
adipose tissue cytokines with functions ranging from inflammatory mediators to metabolic           
regulators. Polyunsaturated fatty acids (PUFAs) have been shown to affect differentiation and            
lipid droplet formation in 3T3-L1 adipocytes, but few studies have examined their effects on              
inflammatory adipokine production from these cells. Adipocyte differentiation, which is marked           
by lipid droplet (triacylglycerol; TAG) accumulation, is regulated by various transcription           
activators, including a splice variant of the nuclear receptor PPAR𝛄. PUFAs are major             
regulators of PPAR𝛄. The objectives of this experiment were to determine the effects of n-3 and                
-6 PUFAs on TAG metabolism, as measured by free fatty acid (FFA) release and lipid droplet                
formation, and inflammatory cytokine production, as measured by interleukin (IL)-6 and           
macrophage inflammatory protein (MIP)-1α production. In order to examine these effects, the            
3T3-L1 cells were differentiated in media with 100µM of PUFA treatment (α-linoleic acid [LA],              
arachidonic acid [ARA], and eicosapentaenoic acid [EPA]), followed by a 6 h, 1µg/mL             
lipopolysaccharide (LPS) challenge. Fully differentiated 3T3-L1 adipocytes under these         
treatments did not release FFA in quantifiable amounts. The ARA+LPS treatment produced a             
significantly higher concentration of MIP-1𝛼 in conditioned media compared to control, LPS,            
and LA+LPS treatments. There was no significant difference in the amount of IL-6 produced              
between treatments. These data suggest that differentiating 3T3-L1 adipocytes in the presence of             
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the n-6 PUFA ARA results in increased release of LPS-stimulated MIP-1𝛼 and indicate a role of                




Adipose tissue is responsible for insulating internal organs, storing energy for times of             
negative energy balance, and secreting adipokines into circulation (Surmi and Hasty, 2008). The             
major cell types found in adipose tissue include undifferentiated adipocytes (pre-adipocytes),           
adipocytes, and adipose tissue macrophages (ATMs). Adipocytes and ATMs are the major            
sources of adipokines. Adipokines are signaling proteins with functions ranging from           
inflammatory mediators to metabolic regulators (Bai and Sun 2015). An example of an             
adipokine is macrophage inflammatory protein 1𝛼 (MIP-1𝛼), which also acts as a            
chemoattractant, and when measured can be an indicator of the presence of other             
proinflammatory cytokines (Schall 1994). Interleukin 6 (IL-6) is another adipokine that is            




Figure 1 Major adipokines released by adipose tissue. Credit: Gustafson et al Inflamed Adipose              
Tissue: A Culprit Underlying the Metabolic Syndrome and Atherosclerosis. Arterioscler Thromb           
VascBiol. 27:2276. 
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The 3T3-L1 cell line of fibroblasts can be differentiated into adipocytes for ​in vitro              
adipocyte studies. During differentiation, these fibroblasts undergo a series of biochemical and            
morphological changes resulting in the accumulation of lipid droplets (Tong and Hotamisligil            
2001). The formation of lipid droplets is due to the synthesis of t​riacylglycerol (TAG) which               
provides a concentrated form of metabolic energy (Gurr et al. 2002). During times of negative               
energy balance, or stimulation by other factors, ​TAGs are catabolized releasing long-chain FAs             
that are imported to the mitochondria for degradation through FA oxidation, which yields ATP              
(​Gurr et al. 2002​). If the long chain FAs are not catabolized they can be released by the                  
adipocytes as free fatty acids (FFAs). Polyunsaturated fatty acids (PUFAs) such as omega-3 and              
omega-6 fatty acids can be released during lipolysis, leading to an increase in local FA               
concentration and subsequent uptake by surrounding adipocytes during differentiation and lipid           
droplet development (Teusink et al. 2003). Adipocyte differentiation, which is marked by lipid             
droplet accumulation, is regulated by various transcription activators, including a splice variant            
of the nuclear receptor PPAR𝛄, as well as by transcription repressors (MacDougald and Lane              
1995). Throughout the differentiation process, genes whose function is to inhibit adipogenesis            
are suppressed through transcriptional regulation (Jessen, Stevens 2002; Gregoire et al. 1998).            
During the differentiation process, the adipocyte also undergoes a change in shape to a more               
spherical form rather than the stringy fibroblast precursor (Kuri-Harcuchet al., 1978). This shape             
change is independent of the formation of the lipid droplet which is an indicator of the presence                 
of lipid binding proteins and the terminal stage of differentiation (Gregoire et al. 1998).  
The size of the adipocyte is an important marker of what adipokines will be secreted               
(Manickam et al. 2010). Increase in TAG storage and total adipose tissue mass can occur through                
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adipocyte hypertrophy and/or adipocyte hyperplasia. Adipocyte hyperplasia is an increase in the            
number of adipocytes whereas hypertrophy is characterized by an increase in the size of              
adipocytes (Jo et al. 2009). Typically, larger adipocytes release proinflammatory adipokines           
whereas smaller adipocytes secrete anti-inflammatory adipokines (Manickam et al. 2010).  
Fatty acids (FAs) are carboxylic acids and are named based on the number of double               
bonds the FA contains. Furthermore, there are two main types of polyunsaturated fatty acids              
(PUFAs), omega-3 and omega-6 . Omega-3 PUFAs have their first double bond located on the               
3rd carbon atom while omega-6 PUFAs have a double bond on the 6th carbon from the methyl                 
end of the molecule (Bayly, 2014). Fatty acids are derived from adipose tissue triglycerides              
through the action of hormone-sensitive lipase which is activated by hormones like glucagon and              
epinephrine (Bayly, 2014). Recent research has shown that the length and degree of unsaturation              
of fatty acids present in media used to culture adipocytes influence PPAR𝛄 regulated gene              
expression which in turn dictates lipid droplet formation during differentiation (Manickam et al.             
2010).  
One of the major FA regulators of PPAR𝛄 expression is eicosapentaenoic acid (EPA)             
which is a long chain omega-3 polyunsaturated fatty acid (Manickam et al. 2010).             
Eicosapentaenoic acid has been shown to have an effect on lipid droplet size through effects on                
lipid catabolism (Manickam et al. 2010), as well as mediate reductions in pro-inflammatory             
adipokine secretion in favor of anti-inflammatory secretions (Flachs et al 2009). Reports on the              
effects of omega-3 and omega-6 PUFAs on adipocyte differentiation and TAG accumulation (as             
measured by lipid droplet size) are conflicting. Madsen et al. (2005) reported that the omega-3               
PUFAs EPA and docosahexaenoic acid (DHA), as well as the omega-6 PUFAs 𝛂-linoleic acid              
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(LA) and arachidonic acid (ARA) stimulated the differentiation and increased TAG           
accumulation in 3T3-L1 cells at concentrations of 100 µM. In contrast, Kim et al. (2006) found                
that 50 and 200 µM doses of DHA inhibited differentiation and lipid droplet accumulation in               
3T3-L1 cells. Lastly, treatment of 3T3-L1 cells with 100 µM of EPA markedly reduced lipid               
droplet size and total lipid accumulation (Manickam et al. 2010). In addition to PUFAs,              
monounsaturated fatty acids (MUFAs) have also been shown to have proinflammatory effects on             
3T3-L1 cells. Previous research has found 3T3-L1 preadipocytes that were acutely exposed to             
MUFAs produced higher levels of MIP-1𝛼 and IL-6 compared to mature 3T3-L1 cells (Dordvic              
et al. 2014). 
It is important to clarify the effects of PUFAs on adipocyte differentiation and to              
determine if these fatty acids have effects on inflammatory molecule production. As common             
dietary fats, PUFAs have the possibility of improving metabolic status by decreasing fat mass              
size, as well as decreasing inflammation coming from adipose tissue. The objectives of these              
experiments were to determine the effects of the PUFAs EPA (omega-3), 𝛼-linoleic acid (LA,              
omega-6) and arachidonic acid (ARA, omega-6) on 3T3-L1 differentiation, as measured by lipid             
droplet size, and inflammatory cytokine production as measured by MIP-1𝛼 and IL-6 production. 
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Methods and Materials 
Reagents 
Murine pre-adipocytes (3T3-L1) were purchased from ATCC (Manassass, VA).         
Dulbecco’s modified Eagle’s medium (DMEM), phosphate buffered saline (PBS), fetal bovine           
serum (FBS), penicillin-streptomycin, dexamethasone, biotin, insulin, and       
3-Isobutyl-1-methylxanthine (IBMX) were purchased from Fisher Scientific (Pittsburg, PA).         
Bovine serum albumins (BSA) was purchased from Sigma Aldrich (St. Louis, MO). Sodium             
salts of fatty acids were from NU-CHEK Prep, Inc. (Waterville, MN). The interleukin (IL)-6              
and macrophage inflammatory protein-1ɑ (MIP1-ɑ) enzyme-linked immunosorbent assays        
(ELISA) were purchased from R&D systems (Minneapolis, MN), while the Griess assay for             
nitric oxide (NO) quantification was obtained from Promega (Madison, Wisconsin).  
 
Cell Culture 
3T3-L1 cells were grown in 10cm plates with DMEM containing 10% FBS, 1%             
Pen-Strep, and 4µg Biotin (complete growth medium; CGM). Cells were incubated in a 95% O​2               
and 5% CO​2 humidified atmosphere. The medium was changed every two-three days, until cells              
reached 75% confluency. Three days after reaching 75% confluence and when cells looked             
clumped together losing fibroblast morphology, differentiation was initiated by aspirating growth           
medium and replacing it with the differentiation cocktail (CGM+ 2.5% IBMX, 0.25% DEX, 0.1              
%insulin). This medium was left on the cells for 48hrs. Following this period, they were fed with                 
the post-differentiation cocktail (CGM + 0.1 % insulin). These post- differentiation feedings            
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occur three times, withmedium being left on the cells for 48hrs between feedings. Cell              
differentiation was confirmed by staining differentiated 3T3-L1 cells with Oil Red-O.  
 
Oil Red-O staining 
Fully differentiated 3T3-L1 cells were washed with 1X PBS. Cells were fixed with the              
addition of 10% formalin and 60% isopropanol followed with a 30 min incubation (after addition               
of each solution).The Oil Red-O solution was added to the cells and left for 20 mins to be                  
discarded and washed 3-5 times with ddH​2​O. The Oil Red-O solution stains the lipid droplets in                
the adipocytes. Hematoxylin was added to the plate for 1 minute and then discarded and washed                
with ddH​2​O. The hematoxylin stains the nuclei of the cells. When viewed under a microscope the                
lipid droplets appeared red and nuclei appeared blue. 
 
3T3-L1 differentiation with PUFAs  
PUFA stock solutions were complexed to BSA in serum free media (SFM) at a 2:1 molar                
ratio for a period of 2 hours prior to plating each day of feeding. Following this period, each                  
treatment was mixed with the corresponding differentiation media along with 200µM           
𝛼-tocopherol, resulting in 100 µM PUFA treatments. The 𝛼-tocopherol solution was added to             
prevent oxidation of PUFAs. Treatments were added to duplicate wells using a 0.2 µm syringe               
filter. The cells incubated for forty eight hours at a time. Forty eight hours following the last                 
post-differentiation feeding, the adipocytes underwent an LPS challenge. The fully differentiated           
3T3-L1 cells were washed 2x with 1X PBS. SFM was added to each well and followed by the                  
addition of 0.1µg/ml of LPS. The cells were then incubated for 6 hours at 37​o​C. Following the                 
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challenge, the supernatant was collected and stored for use in FFA assays, MIP-1𝛼 and IL-6               
ELISAs. 
Enzyme-linked immunosorbent assay 
Analyses of samples for determination of cytokine levels were done using IL-6 and             
MIP-1ɑ ELISAs according to manufacturer’s instructions. These ELISAs use the sandwich           
technique where the cytokines produced by the samples are bound to the antibody of the               
cytokine in the wells of the plate. From here a polyclonal antibody specific to the cytokine being                 
examined is added. Finally a substrate solution is added, causing the wells to change colors as                
well as a stop solution before reading the plate. The intensity of the color is proportional to the                  
amount of cytokine present. Samples were tested in triplicate, and a standard curve was produced               
and used to extrapolate the cytokine concentrations in the samples. 
 
Free fatty acid quantification 
Analysis of samples for determination of free fatty acid levels were done using a Fatty               
acid assay from BioAssay Systems according to manufacturer’s instructions. The free fatty acids             
are converted into acyl-CoA and then H​2​O​2​. The H​2​O​2 ​reacts with dye and produces a pinkish                
color that is directly related to the concentration of free fatty acids present. Samples were tested                
in triplicate, and a standard curve was produced and used to extrapolate the cytokine              





Statistical analyses  
Concentrations of IL-6 and MIP-1ɑ in cell culture medium and were analyzed using             
two-way ANOVAs (JMP Pro 13). Interleukin-6 and MIP-1ɑ data were normalized using a log              
transformation. The sources of variation included experiment, treatment, and experiment x           
treatment interaction, with the experiment and treatment x experiment interaction considered as            





Oil Red-O staining 
3T3-L1 cells were stained following the differentiation protocol in order to confirm            
successful differentiation (Figure 2). The Oil Red-O stains the lipid droplets which develop             
following the differentiation process. From these images, one can see the morphological            
differences between them. The right image shows fibroblasts that are elongated. This shape is              
lost during the differentiation process as the cells become larger, rounded, and take up              
triglycerides which are stored in the visible lipid droplets shown in the left image. 
 
Figure 2 Left image: Fully Differentiated 3T3-L1 cells (passage 5) stained with Oil Red-O. Right               
image: 3T3-L1 (passage 5) at 70% confluency before initiation of the differentiation process. 
 
 
MIP-1​𝛂 ​ concentrations in conditioned media  
3T3-L1 cells differentiated with arachidonic acid and then stimulated with LPS (1 μg/ml)             
showed the highest concentration of MIP- 1𝛂 in conditioned media (26.315 ± 2.54 pg/mL)              
whereas cells treated with only LPS produced the lowest concentration of MIP- 1𝛂 (0.06 ± 2.54                
11 
pg/mL) (Tukey-Kramer; p<0.05) (Figure 3). These results are consistent with previous research            
from Cranmer-Byng et al. 2015, which showed that 3T3-L1 cells produced higher concentration             
of MIP- 1𝛂 when ARA and LPS were present in culture conditions. Although differentiating the               
adipocytes with linoleic acid resulted in numerically higher MIP-1𝛂 concentrations following           
LPS stimulation (7.482 ± 2.54 pg/mL) compared to control (0.55 ± 2.54 pg/mL) and              
LPS-challenged cells, there was no statistical difference in MIP-1𝛂 production among these three             
treatments. Additionally, MIP-1𝛂 production by LA-differentiated adipocytes was not         
significantly different than MIP-1𝛂 production by ARA or EPA-differentiated cells (14.93 ± 2.54             
pg/mL) following LPS challenge. 
 
Figure 3 Mean MIP-1𝛂 (pg/ml) production of 3T3-L1 cells challenged with LPS and             
preincubated with various PUFA treatments. ARA treatment had the highest MIP- 1𝛂 production             
compared to other treatments (p=0.027). Bars are mean; error bars are SEM. Groups were              
compared by two-way ANOVA, followed by post-hoc Tukey- Kramer HSD; significant group            
differences are represented with letters (p<0.05). Treatments were performed in duplicate.           
Values are the means of four experiments. 
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IL-6 concentrations in conditioned media 
There was no significant difference in the production of IL-6 between treatments            
(two-way ANOVA; p=0.95). The average concentration of IL-6 produced by the differentiated            
adipocytes was 115.36 ± 68.70pg/ml.  
Figure 4 Mean IL-6 (pg/ml) production of 3T3-L1 cells challenged with LPS and preincubated              
with various PUFA treatments. There was no differences in IL-6 production among treatments             
(p=0.95). Bars are mean; error bars are SEM. Groups were compared by two-way ANOVA.              
Treatments were performed in duplicate. Values are the means for four experiments. 
 
Lipid droplet appearance 
Figure 5 contains images of all six treatments after the cells were fully differentiated.              
This comparison allowed us to both confirm that differentiation with the PUFA treatments was              
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successful as well as visually compare the differences in lipid droplet development, a hallmark of               
differentiation. While one can see visual differences in size of lipid droplets across the              
treatments, we were unable to statistically quantify any differences in size.  
Figure 5 Images of differentiated 3T3-L1 cells treated with LPS and PUFAs. Image A shows               
control cells stained with Oil Red-O, which stains the lipid droplets. Images B-E were not               
stained with Oil Red-O. B=LPS treatment; C=LPS+LA treatment; D=LPS+ARA treatment;          
E=LPS+EPA treatment. 
Free Fatty Acid concentrations in conditioned media 
The amount of free fatty acid produced by the treatments was less than the lower standard                
of the assay (<7 micromoles/liter) and therefore below the level of detection of this assay. Data is                 
not shown.  
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Discussion 
Fully differentiated 3T3-L1 adipocytes did not release FFA in quantifiable amounts (data            
not shown), but did produce measurable amounts of both IL-6 and MIP-1𝛼. The values we               
quantified were much lower than those reported by Chirumbolo et al. (2014) despite the use of                
the same LPS concentration (1 µg/ml) and similar LPS-incubation length (6 hours vs 8 hours).               
Chirumbolo et al. reported that incubation of differentiated 3T3-L1 cells with 1 µg/ml of LPS for                
8 hours resulted in production of 800 pg/ml of IL-6 and 50 pg/ml of MIP-1𝛼. We quantified                 
115.36±68.7 pg/ml of IL-6 and 9.86±2.54 pg/ml MIP-1𝛼 produced by differentiated adipocytes            
treated with 1 µg/ml LPS for 6 hours. There was no difference in MIP-1𝛼 cytokine production                
between control and LPS stimulated cells (0.55 ±2.54 pg/ml and 0.06±2.54 pg/ml, respectively).             
This could be attributed to the adipocytes inherently producing MIP-1𝛼 and other cytokines             
regardless of the presence of LPS. These results suggest that our current methodology of              
differentiating 3T3-L1 cells with fatty acids and LPS may cloud our ability to examine the               
amount of cytokines produced by the cells in the presence of FAs. Additional experiments need               
to be conducted with 3T3-L1 cells differentiated with FAs but without the LPS challenge in               
order to further examine this.  
Our results suggest that 3T3-L1 adipocytes differentiated with 100 µM of ARA produced             
significantly more MIP-1𝛼 after 6 hours of LPS-stimulation compared to the other treatments.             
However, there was not a significant difference in production of IL-6 between the LPS and               
LPS+fatty acid treatments following 6 hours of LPS-stimulation. This differs from results            
obtained by Cranmer-Byng et al. (2015) who reported that a 24 hour treatment of fully               
differentiated 3T3-L1 adipocytes with ARA and LPS increased pro- inflammatory monocyte           
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chemoattractant protein-1 (MCP)-1 and interleukin IL-6 secretion and gene expression, but did            
not observe an increase in production of proinflammatory proteins in adipocytes treated with             
other omega-6 and omega-3 PUFAs. Monocyte chemoattractant protein-1 (MCP-1) is also           
referred to as CCL2 and functions similar to MIP-1𝛼, by recruiting immune cells to sites of                
inflammation. Despite the differences in methodology, the difference in results obtained by our             
lab and Cranmer-Byng’s results (2015) suggests that treating 3T3-L1 cells with ARA can induce              
proinflammatory adipokine release independent of if the treatment occurs pre- or           
post-differentiation. Additional investigation is needed to determine whether the adipocytes          
produce these cytokines as a response to LPS or if it is an inherent occurrence. We hypothesize                 
that the increase in proinflammatory adipokines is related to an increased production of             
prostaglandin E2 (PGE2), an inflammatory prostanoid, which subsequently results in increased           
production of other proinflammatory adipokines. Prostanoids are made from ARA, and research            
has shown that ARA inhibits lipogenic gene expression in 3T3-L1 adipocytes through a             
prostanoid pathway (Mater et al., 1998). If ARA is inhibiting lipogenesis the result should be               
smaller adipocytes and less inflammatory cytokines being produced. Our results seem to            
contradict this sentiment since ARA produced the highest concentration of MIP-1𝛼. Further            
investigation is needed to determine if ARA-differentiated adipocytes produce higher          
concentrations of PGE2 and if there is a difference in LD development. 
Unfortunately, we were not able to develop a methodology to quantify adipocyte            
hypertrophy, hyperplasia, or lipid droplet size. We are currently seeking assistance in developing             
a methodology to measure these. Since Oil Red-O stains lipid droplets of differentiated 3T3-L1              
adipocytes, perhaps using an image software such as ImageJ to measure the intensity of the stain                
16 
will allow us to measure LD development. Another possibility is running a colorimetric assay,              
similar to some ELISAs and GREISS assays to measure differences in intensity of color              
produced (in this case Oil Red-O stain). This method is similar to Manickam et al. (2010), who                 
reported quantifying LD development using Oil Red-O stain and spectrophotometric analysis.  
Future experiments should examine if there is an effect on cytokine production when the              
3T3-L1 cells are differentiated with FAs but without the LPS challenge. Additionally, analysis of              
our samples using a PGE2 ELISA to explore the proposed hypothesis above regarding the effects               
of ARA on PGE2 production should be performed. The PPAR𝛄 antagonist GW9662 can also be               
used to determine if ARA is exerting its proinflammatory effects through this nuclear receptor.              
In an effort to further explore the relationship between adipocytes and other adipose tissue cells               
the 3T3-L1 cells can be differentiated in the presence of these other cells using transwells plates.                
This method would allow for the further study of cross communication between the adipocytes              




Bai Y and Sun Q. 2015. Macrophage recruitment in obese adipose tissue. Obesity Reviews              
16(2):127-36. 
Bas Teusink, Peter J. Voshol, Vivian E.H. Dahlmans, Patrick C.N. Rensen, Hanno Pijl,             
Johannes A. Romijn, Louis M. Havekes. 2003. Contribution of fatty acids released            
from lipolysis of plasma triglycerides to total plasma fatty acid flux and tissue-specific             
fatty acid uptake. Diabetes 52(3):614-20. 
Bayly GR. 2014. CHAPTER 37 - lipids and disorders of lipoprotein metabolism. In:             
Clinical biochemistry. Third Edition ed. Elsevier Ltd. 702 p. 
Chirumbolo S, Franceschetti G, Zoico E, Bambace C, Cominacini L, Zamboni M. 2014.             
Erratum to: LPS response pattern of inflammatory adipokines in an in vitro 3T3-L1             
murine adipocyte model. Inflamm Res 63(6):509-12. 
Cranmer-Byng MM, Liddle DM, De Boer AA, Monk JM, Robinson LE. 2015.            
Proinflammatory effects of arachidonic acid in a lipopolysaccharide-induced        
inflammatory microenvironment in 3T3-L1 adipocytes in vitro. Applied Physiology,         
Nutrition, and Metabolism 40(2):142-54. 
Dordevic AL, Konstantopoulos N, Cameron-Smith D. 2014. 3T3-L1 preadipocytes exhibit          
heightened monocyte-chemoattractant protein-1 response to acute fatty acid exposure.         
PloS One 9(6):e99382. 
Fain JN. 2010. Release of inflammatory mediators by human adipose tissue is enhanced in              
obesity and primarily by the nonfat cells: A review. Mediators of Inflammation            
2010:513948-20. 
Flachs P, Rossmeisl M, Bryhn M, Kopecky J. 2009. Cellular and molecular effects ofn−3              
polyunsaturated fatty acids on adipose tissue biology and metabolism. Clinical Science           
116(1):1-16. 
Gregoire, Francine; Smas, Cynthia; Sul, Hei. 1998. Understanding adipocyte differentiation.          
Physiological Reviews 78(3):783-809. 
Green H and Kuri-Harcuch W. 1978. Adipose conversion of 3T3 cells depends on a serum               
factor. Proceedings of the National Academy of Sciences of the United States of             
America 75(12):6107-9. 
Gurr W, Reza Yavari, Li Wen, Margaret Shaw, Conchi Mora, Laurence Christa, Robert S.              
Sherwin. 2002. A reg family protein is overexpressed in islets from a patient with              
new-onset type 1 diabetes and acts as T-cell autoantigen in NOD mice. Diabetes             
51(2):339-46. 
Gustafson B, Hammarstedt A, Andersson CX, Smith U. 2007. Inflamed adipose tissue: A             
culprit underlying the metabolic syndrome and atherosclerosis. Arteriosclerosis,        
Thrombosis, and Vascular Biology 27(11):2276-83. 
18 
Jessen BA and Stevens GJ. 2002. Expression profiling during adipocyte differentiation of            
3T3-L1 fibroblasts. Gene 299(1-2):95-100. 
Jo J, Gavrilova O, Pack S, Jou W, Mullen S, Sumner AE, Cushman SW, Periwal V. 2009.                 
Hypertrophy and/or hyperplasia: Dynamics of adipose tissue growth. PLoS         
Computational Biology 5(3):e1000324. 
Kim H, Della-Fera M, Lin J, Baile CA. 2006. Docosahexaenoic acid inhibits adipocyte             
differentiation and induces apoptosis in 3T3-L1 preadipocytes. The Journal of Nutrition           
136(12):2965-9. 
MacDougald OA. 1995. Transcriptional regulation of gene expression during adipocyte          
differentiation. Annual Review of Biochemistry 64(1):345-73. 
Madsen L, Petersen RK, Kristiansen K. 2005. Regulation of adipocyte differentiation and            
function by polyunsaturated fatty acids. BBA - Molecular Basis of Disease           
1740(2):266-86. 
Manickam E, Sinclair AJ, Cameron-Smith D. 2010. Suppressive actions of eicosapentaenoic           
acid on lipid droplet formation in 3T3-L1 adipocytes. Lipids in Health and Disease             
9(1):57. 
Schall TJ and Bacon KB. 1994. Chemokines, leukocyte trafficking, and inflammation.           
Current Opinion in Immunology 6(6):865-73. 
Surmi BK and Hasty AH. 2008. Macrophage infiltration into adipose tissue: Initiation,            
propagation and remodeling. Future Lipidol 3(5):545-56. 
Tong Q and Hotamisligil GS. 2001.  Molecular mechanisms of adipocyte differentiation. ​. 
 
 
19 
